First Shanghai Investments

First Shanghai Investments Limited is a Hong Kong-listed investment conglomerate with a diversified portfolio that includes financial services, property development, and healthcare. The company's healthcare presence is anchored by its Medical and Healthcare segment, which operates the Hong Kong International Medical Centre (HKIMC), providing a range of medical services such as specialist consultations, diagnostic imaging, and day surgery. In the pharmaceutical sector, First Shanghai operates through its subsidiary Crimson Pharmaceutical (Hong Kong) Limited and maintains strategic investments in other entities, having historically held a majority stake in the European manufacturer Sirton Pharmaceuticals. The group leverages its investment expertise to target opportunities in pharmaceutical development and medical service delivery within the Greater China region.